The FDA has approved a COVID-19 test that can provide results while patients wait.
News & Analysis: Abbott Laboratories
Investors are worrying about the impact from the coronavirus on business in China.
The stock falls hard after a short-seller takes aim at the company.
Shares slide after news breaks that a competitor's product nabs an important reimbursement win.
Earnings, insider buying, and criminal probes? Oh, my!
The company is reassuring investors that a new investigation into its billing practices isn't a big deal.
Abbott agrees to buy the medical-device maker.
Less-than-convincing comments from acquirer Abbott Labs are causing a sell-off.
A top- and bottom-line miss last quarter offset otherwise solid results.